Coronavirus Cases India:India reported less than 50,000 cases for 12th consecutive day
New Delhi:
India’s COVID-19 tally inched closer to the 90-lakh mark with 45,576 confirmed cases on Thursday, according to the Union Ministry of Health and Family Welfare.
The country’s Covid-19 tally has risen to 89,58,484 including 83,83,602 recoveries and 4,43,303 active cases. With 585 new deaths, the cumulative count mounted to 1,31,578.
This is the twelfth consecutive day when India reported less than 50,000 cases in a day. The last time daily new cases crossed the 50,000-threshold was on November 7.
The new recoveries continue to overtake the daily new cases continuously since the past 47 days. India’s active caseload has fallen under the five per cent mark today, according to an official press release.
Here are the LIVE updates on Coronavirus Cases:
US President-elect Joe Biden said Thursday he would not order a nationwide shutdown to fight the Covid-19 pandemic despite a surge in cases.
States and cities have been imposing their own restrictions, including home confinement, the closure of indoor dining and a limit on gatherings as infections soar across the country.
“There’s no circumstance which I can see that would require total national shutdown. I think that would be counterproductive,” Biden, who takes office on January 20, told reporters.
He said however that rules for when and how businesses and other establishments can open would have to be calibrated based on the threat in the area in question, noting the varying levels of spread throughout the country.
The anti-viral drug remdesivir should not be used to treat Covid-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday.
Scratching one of the few treatments that had shown some initial promise in severe patients, a WHO Guideline Development Group (GDG) of international experts said there was “no evidence based on currently available data that it does improve patient-important outcomes”.
The United States, the European Union and other countries have granted temporary approval for the use of remdesivir after initial research showed it may shorten recovery time in some coronavirus patients.
